Ryan Zeidan, Ph.D.

Chief Development Officer

Dr. Zeidan’s in-depth industry knowledge spans a number of therapeutic areas and modalities. Most recently at Celgene, he oversaw the development of two late-stage oncology assets in a variety of tumor types, including advancing both assets to Phase 3 registration studies. Prior to Celgene, Dr. Zeidan was executive director, global strategy and operations, at Novartis Oncology, where he supported the company in business critical activities, including developing the five-year strategic plan and investor relations matters. Dr. Zeidan also worked at the Boston Consulting Group, where he focused on pharmaceutical and biotech strategy, and at Calando Pharmaceuticals, a biotech startup, where he was one of the key scientific contributors.

Dr. Zeidan holds a Ph.D. in chemistry and chemical engineering from the California Institute of Technology, and bachelor’s degrees in chemistry and chemical engineering from the Massachusetts Institute of Technology.


US Offices

Corporate Headquarters

110 Miller Avenue, Suite 100
Ann Arbor, MI 48104

Europe Office

Lyon Office

Millendo Therapeutics SAS
c/o Canopee consulting
8 rue Berjon
69009 Lyon
Tel +33 472 18 94 28

Lexington Office

420 Bedford Street,
Suite 260
Lexington, MA 02420

Scroll to Top